Karl Freimuth i Medtech Intelligence om M&A och robotteknik

Although medical device companies continue to be careful with their budgets, they are still on watch and are making room for strategic acquisitions that will bring a big boost to their portfolios. In a brief interview with MedTech Intelligence, Karl Freimuth, partner and co-head of the U.S. industrials practice at Livingstone, an independent M&A and advisory firm, expands on his latest report, “2018 Year in Review & 2019 Outlook” and what he sees as key industry drivers, challenges and opportunities.

Read the full article on the Medtech Intelligence site.

Dela sidan


Håll dig uppdaterad Missa inga affärer eller analyser